Chronic hepatitis C infection in patients with end stage renal disease: Characterization of liver histology and viral load in patients awaiting renal transplantation

American Journal of Gastroenterology

Volumn 94, Issue 12, 1999, Pages 3576-3582

  Sterling, Richard K ^a,b   Sanyal, Arun J ^a   Luketic, Velimir A ^a   Stravitz, R Todd ^a   King, Anne L ^a   Post, Anthony B ^b   Mills, A Scott ^a   Contos, Melissa J ^a   Shiffman, Mitchell L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEPATITIS C; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER HISTOLOGY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; VIRUS LOAD;

EID: 0032787332     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00708-X     Document Type: Article

References (45)

1. Braun W.E., McCauley J. Post-transplant outpatient care. Norman D.J., Suki W.N. Primer on transplantation. 1998;229-244 American Society of Transplant Physicians, New Jersey.
2. Toussaint C., Kinnaert P., Vereerstraeten P. Late mortality and morbidity five to eighteen years after kidney transplantation. Transplantation. 45:1988;554-558.
3. Martin P., Friedman L.S. Chronic viral hepatitis and management of chronic renal failure. Kidney Int. 47:1995;1231-1241.
4. Chan T.M., Lok A.S.F., Cheng I.K.P., et al. A prospective study of hepatitis C virus infection among renal transplant recipients. Gastroenterology. 104:1993;862-868.
5. Chan T.M., Lok A.S.F., Cheng I.K.P., et al. Prevalence of hepatitis C virus infection in hemodialysis patients A longitudinal study comparing the results of RNA and antibody assays . Hepatology. 17:1993;5-8.
6. Pol S., Romeo R., Zins B., et al. Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients. Significance and therapeutic implications. Kidney Int. 44:1993;1097-1100.
7. Huang C.S., Ho M.E., Yang C.S., et al. Hepatitis C markers in hemodialysis patients. J Clin Microbiol. 31:1993;1764-1769.
8. Kazi S., Prasad S., Pollak R., et al. Hepatitis C infection in potential recipients with nomal liver biochemistry does not preclude renal transplantation. Dig Dis Sci. 39:1994;961-964.
9. Druwe P.M., Michielsen P.P., Ramon A.M., et al. Hepatitis C and nephrology. Nephrol Dial Transplant. 9:1994;230-237.
10. Al Meshari K., Al Ahdal M., Alfurayh O., et al. New insights into hepatitis C virus infection of hemodialysis patients The implications . Am J Kidney Dis. 25:1995;572-578.
11. Murthy B.V.R., Pereira B.J.G. A 1990s perspective of hepatitis C, human immunodeficiency virus, and tuberculosis infections in dialysis patients. Sem Nephrol. 17:1997;346-363.
12. Yasuda K., Okuda K., Endo N., et al. Hypoaminotransferasemia in patients undergoing long-term hemodialysis Clinical and biochemical appraisal . Gastroenterology. 109:1995;1295-1300.
13. Gilli P., Cavazzini L., Stabellini N., et al. Histological features of non-A, non-B hepatitis in hemodialysis patients. Nephron. 61:1992;296-297.
14. Caramelo C., Ortiz A., Aguilera B., et al. Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus. Am J Kidney Dis. 22:1993;822-828.
15. Demirhan B., Boyacioglu S., Kart H., et al. Histopathologic features of hepatitis C virus infection in patients with chronic renal failure and renal transplantation. Tranplant Proc. 28:1996;2328-2330.
16. Knodell R.G., Ishak K.G., Black W.C., et al. Formulation and application of a numerical scoring system for assessing histologic activity in asymptomatic chronic active hepatitis. Hepatology. 1:1981;431-435.
17. Shiffman ML, Reddy KR, Hofmann CM, et al. Comparison of Chiron branched chain-DNA and Roche Amplicor quantitative PCR assays in patients with chronic hepatitis C virus infection. Hepatology 1996;24:385A (abstract).
18. Favero M.S., Alter M.J., Bland L.A. Nosocomial infections associated with hemodialysis. Hospital epidemiology and infection control. 1996;693-714 Williams &Wilkins, Philadelphia.
19. Almroth G., Ekermo B., Franzen L., et al. Antibody responses to hepatitis C virus and its mode of transmission in dialysis patients. Nephron. 59:1991;232-235.
20. Kallinowski B., Theilmann L., Gmelin K., et al. Prevalence of antibodies to hepatitis C virus in hemodialysis patients. Nephron. 59:1991;236-238.
21. Umlauft F., Gruenewald K., Weiss G., et al. Patterns of hepatitis C viremia in patients receiving hemodialysis. Am J Gastroenterol. 92:1997;73-78.
22. Simon N., Courouce A.M., Lemarrec N., et al. A twelve year natural history of hepatitis C virus infection in hemodialyzed patients. Kidney Int. 46:1994;504-511.
23. Knoll G.A., Tankersley M.R., Lee J.Y., et al. The impact of renal transplantation on survival in hepatitis C positive end-stage renal disease patients. Am J Kidney Dis. 29:1997;608-614.
24. Pereira B.J.G., Natov S.N., Bouthot B.A., et al. Effect of hepatitis C infection and renal transplantation on survival in end-stage renal disease. Kidney Int. 53:1998;1374-1381.
25. Stempel C.A., Lake J., Kuo G., et al. Hepatitis C - Its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Transplantation. 55:1993;273-276.
26. Ynares C., Johnson H.K., Kerlin T., et al. Impact of pretransplant hepatitis C antibody status upon long-term patient and renal allograft survival - a 5- and 10-year follow-up. Transplant Proc. 25:1993;1466-1468.
27. Roth D., Zuker K., Cirocco R., et al. A prospective study of hepatitis C virus infection in renal allograft recipients. Transplantation. 61:1996;886-889.
28. Mathurin P., Mouquet C., Poynard T., et al. Impact of hepatitis B and C virus on kidney transplant outcome. Hepatology. 29:1999;257-263.
29. Periera B.J.G., Wright T.L., Schmid C.H., et al. The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation. Transplantation. 60:1995;799-805.
30. Legendre C., Garrigue V., Le Bihan C., et al. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation. 65:1998;667-670.
31. Rao K.V., Ma J. Chronic viral hepatitis enhances the risk of infection but not acute rejection in renal transplant recipients. Transplantation. 62:1996;1765-1769.
32. Hestin D., Guillemin F., Castin N., et al. Pretransplant hepatitis C virus infection. A predictor of proteinuria after renal transplantation. Transplantation. 65:1998;741-744.
33. Morales J.M., Muñoz M.A., Castellano G., et al. Impact of hepatitis C in long-functioning renal transplants A clinicopathologic follow-up . Transplant Proc. 25:1993;1450-1453.
34. Chan T.M., Wu P.C., Lau J.Y.N., et al. Clinicopathologic features of hepatitis C virus infection in renal allograft recipients. Transplantation. 58:1994;996-1000.
35. Rostaing L., Rumeau J.L., Cisterne J.M., et al. Liver histology in renal transplant patients after more than 10 years of hepatitis C infection. Transplant Proc. 28:1996;2836-2837.
36. Zylberberg H, Carnot F, Mamzer MF, et al. Hepatitis C virus-related fibrosing cholestatic hepatitis after renal transplantation. Transplantation.7;1999;63:158-60.
37. Rostaing L., Izopet J., Cisterne J.M., et al. Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients. Transplantation. 65:1998;930-936.
38. Kovarik J., Mayer G., Pohanka E., et al. Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Transplantation. 45:1988;402-405.
39. Thervet E., Pol S., Legendre C., et al. Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients. A pilot study. Transplantation. 58:1994;625-628.
40. Ozgur O., Boyacioglu S., Telatar H., et al. Recombinant alpha-interferon in renal allograft recipients with chronic hepatitis C. Nephrol Dial Transplant. 10:1995;2104-2106.
41. Rostaing L., Izopet J., Baron E., et al. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation. 59:1995;1426-1431.
42. Koenig P., Vogel W., Umlauft F., et al. Interferon treatment for chronic hepatitis C virus infection in uremic patients. Kidney Int. 45:1994;1507-1509.
43. Ozyilkan E., Simsek H., Uzunalimoglu B., et al. Interferon treatment of chronic active hepatitis C in patients with end-stage chronic renal failure. Nephron. 71:1995;156-159.
44. Pol S., Thiers V., Carnot F., et al. Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients. Kidney Int. 47:1995;1412-1418.
45. Roth D. Hepatitis C virus infection and the renal allograft recipient. Nephron. 71:1995;249-253.